![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GlaxoSmithKline Pharma to Make Vaccines
GlaxoSmithKline Pharma to Make Vaccines
February 22, 2005
GlaxoSmithKline Pharmaceuticals said on Tuesday it will manufacture vaccines in Nasik at a plant that will start operations in early 2006. Vaccines produced at the plant are mainly targeted at the Indian market, but they could be used for requirements in neighboring countries too, GlaxoSmithKline said in a statement. It said vaccines for India were currently developed and packaged at its vaccines headquarters in Belgium.
Yahoo News (http://in.news.yahoo.com/050222/137/2jroi.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct